Up a level |
Sanchez-Velazquez, Ricardo, de Lorenzo, Giuditta, Tandavanitj, Rapeepat, Setthapramote, Chayanee, Bredenbeek, Peter J, Bozzacco, Leonia, MacDonald, Margaret R, Clark, Jordan J, Rice, Charles M, Patel, Arvind H et al (show 2 more authors)
(2020)
Generation of a reporter yellow fever virus for high throughput antiviral assays.
ANTIVIRAL RESEARCH, 183.
104939-.
Zhou, Jie, Peacock, Thomas P, Brown, Jonathan C, Goldhill, Daniel H, Elrefaey, Ahmed ME, Penrice-Randal, Rebekah ORCID: 0000-0002-0653-2097, Cowton, Vanessa M, De Lorenzo, Giuditta, Furnon, Wilhelm, Harvey, William T et al (show 19 more authors)
(2022)
Mutations that adapt SARS-CoV-2 to mink or ferret do not increase fitness in the human airway.
Cell Reports, 38 (6).
p. 110344.
Davis, Chris, Logan, Nicola, Tyson, Grace, Orton, Richard, Harvey, William T, Perkins, Jonathan S, Mollett, Guy, Blacow, Rachel M, Peacock, Thomas P, Barclay, Wendy S et al (show 8 more authors)
(2021)
Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccination.
PLOS Pathogens, 17 (12).
e1010022-e1010022.
Willett, Brian J, Grove, Joe, MacLean, Oscar A, Wilkie, Craig, De Lorenzo, Giuditta, Furnon, Wilhelm, Cantoni, Diego, Scott, Sam, Logan, Nicola, Ashraf, Shirin et al (show 31 more authors)
(2022)
SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway.
NATURE MICROBIOLOGY, 7 (8).
1161-+.
Willett, Brian J, Grove, Joe, MacLean, Oscar A, Wilkie, Craig, De Lorenzo, Giuditta, Furnon, Wilhelm, Cantoni, Diego, Scott, Sam, Logan, Nicola, Ashraf, Shirin et al (show 31 more authors)
(2022)
SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway (vol 7, pg 1161, 2022).
NATURE MICROBIOLOGY, 7 (10).
p. 1709.
Salas, Jordan H, Urbanowicz, Richard A ORCID: 0000-0002-2461-4993, Guest, Johnathan D, Frumento, Nicole, Figueroa, Alexis, Clark, Kaitlyn E, Keck, Zhenyong, Cowton, Vanessa M, Cole, Sarah J, Patel, Arvind H et al (show 9 more authors)
(2021)
An antigenically diverse, representative panel of envelope glycoproteins for HCV vaccine development.
Gastroenterology, 162 (2).
pp. 562-574.